Blockade of central 5-hydroxytryptamine receptors by methiothepin.
D000818:Animals; D001952:Bridged-Ring Compounds; D002415:Cats; D003988:Dibenzothiepins / Q000494:pharmacology*; D005071:Evoked Potentials; D005260:Female; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D010879:Piperazines / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011955:Receptors, Drug / Q000187:drug effects; D017981:Receptors, Neurotransmitter / Q000187:drug effects; D012154:Reticular Formation / Q000187:drug effects; D012701:Serotonin / Q000378:metabolism; D012702:Serotonin Antagonists; D013440:Sulfides / Q000494:pharmacology; D013569:Synapses / Q000187:drug effects*; D014149:Tranquilizing Agents / Q000494:pharmacology*
D001952:Bridged-Ring Compounds; D003988:Dibenzothiepins; D010879:Piperazines; D011955:Receptors, Drug; D017981:Receptors, Neurotransmitter; D012702:Serotonin Antagonists; D013440:Sulfides; D014149:Tranquilizing Agents; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid